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Abstract.  Protein prenylation is a posttranslational 
modification involving the covalent attachment of a 
prenyl lipid to a  cysteine at or near the COOH termi- 
nus of a protein.  It is required for membrane localiza- 
tion and efficient function of a  number of cytoplasmic 
as well as nuclear proteins including the proto-onco- 
genic and activated forms of Ras.  Farnesylation in 
conjunction with a  nuclear localization signal has been 
shown to be necessary to target newly synthesized nu- 
clear lamins to the inner nuclear envelope membrane. 
It is, however, not clear where in the cell isoprenyla- 
tion of nuclear lamins takes place.  In this study we 
describe in vivo and in vitro experiments on the 
isoprenylation of the Xenopus oocyte nuclear lamin 
B3.  We show by kinetic analysis that newly synthe- 
sized lamins are isoprenylated in the cytosol of oo- 
cytes before uptake into the nucleus. From our data it 
can be concluded that isoprenylation of lamins in the 
nucleus, as it is observed under certain conditions of 
isoprene starvation, represents a  default pathway rather 
than the physiological situation. We further analyzed 
the capacity of isolated nuclei to carry out isoprenyla- 
tion of B3.  Our results are in line with a dual localiza- 
tion of a  protein farnesyltransferase in the cytosol and 
nuclei of amphibian oocytes. Implications for the pos- 
sible functions of a  nuclear protein farnesyltransferase 
as well as possible mechanisms of the selective inhibi- 
tion of farnesylation of cytoplasmic proteins by pep- 
tidomimetics are discussed. 
UKARYOTIC polypeptides with certain types of cys- 
teine-containing carboxy-terminal sequence  motifs 
are candidates for posttranslational modifications in- 
cluding isoprenylation, proteolytic cleavage, and methyl es- 
terification. The major class of these proteins contains a 
COOH-terminal CXXX tetrapeptide (C  =  cysteine, X  = 
generally aliphatic). Most prenylated proteins are modified 
by attachment of either a 15-carbon farnesyl or a 20-carbon 
geranylgeranyl group in a thioether linkage to the cysteine 
residue. Proteins that contain these sequence motifs include 
the Ras proteins and many other small G proteins, the hetero- 
trimeric  large  G  proteins,  the  retinal  cGMP  phosphodi- 
esterases, most nuclear lamins, and several  fungal mating 
pheromones (for review see references 9,  10, 40). 
For many of these proteins the importance of prenylation 
for their function has been shown (3, 8, 19, 22, 29). The pre- 
cise mechanism, however, by which these modifications ex- 
ert their function is not clear at present. Isoprenylation and 
carboxyl methylation result in an increased hydrophobicity 
of the carboxyl terminus (4). This has been taken to explain 
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the affinity of many prenylated proteins for membranes. In 
other cases the primary effect of prenylation seems to be a 
strengthening of protein-protein interaction that can be ob- 
served even in the absence of membranes (15). For several 
of the membrane bound proteins such as Ras proteins and 
B-type lamins it has been shown, that the CXXX motif  medi- 
ated modifications, although necessary,  are  not in theria- 
selves sufficient for a tight association with membranes, and 
that additional factors are involved in membrane binding (13, 
17, 18). Membrane receptor proteins, that recognize the iso- 
prenyl and methyl groups might be involved in targeting such 
proteins to membranes. 
Several  enzymes,  termed  protein  prenyltransferases, 
which catalyze the attachment of  a prenyl moiety to proteins, 
have been identified (for review see 6,  9, 40).  Depending 
on their substrate  specificity they are  classified as either 
farnesyl  or  geranylgeranyl  protein  transferases.  Protein 
farnesyltransferases are  soluble enzymes.  Their  substrate 
specificity is confined to the four amino acids of the CXXX 
motif,  Farnesylation of all the above mentioned proteins 
could therefore be carried out by a single cytosolic enzyme. 
Proteins carrying the same CXXX-dependent modifications 
are located in different membrane compartments, therefore 
additional factors must be responsible for the specific target- 
ing of these proteins.  In the case of Ras proteins efficient 
binding to the plasma membrane has been shown to depend 
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another cysteine, or the presence of a polybasic domain in 
close proximity to the isoprenylated COOH terminus (17, 
18).  The translocation of the transducin/~3' complex from 
the cytosol to the rod outer segment membranes might be 
achieved by the CXXX-dependent modifications of the ~/ 
subunit that increases the interaction with membrane as- 
sociated transducin c~ and rhodopsin (15, 36).  Mutational 
analysis has shown that targeting of lamins to the inner nu- 
clear membrane requires in addition to the CXXX-mediated 
modifications a nuclear localization signal (21, 26, 28, 31). 
It is, however, not known whether newly synthesized lamins 
are isoprenylated in the cytoplasm before entering the nu- 
cleus or whether nuclear entry precedes the modification 
reactions. In the latter case isoprenylation would take place 
within the nucleus and due to the lipophilic modifications 
lamins would be concentrated at the inner nuclear membrane 
where filament formation would be initiated. 
We have analyzed isoprenylation of nuclear lamin B3 in 
Xenopus oocytes.  We  show here by kinetic analysis that 
newly synthesized lamins are isoprenylated in the cytosol be- 
fore uptake into the nucleus and that isoprenylation of lamin 
B3 can be achieved in vitro by incubation with cytosol of 
enucleated oocytes. However,  in vitro experiments demon- 
strate that isoprenylation of lamins can also occur in isolated 
nuclei and evidence is given that these in vitro prenylated 
lamins are integrated into the lamina structure. These results 
are discussed in the light of the recent finding of the dual lo- 
calization of the protein farnesyltransferase in cytosol and 
nuclei (44) and pose the question of the possible function of 
a nuclear protein farnesyltransferase. 
Materials and Methods 
Biosynthetic Labeling  of  Xenopus laevis Oocytes 
Oocytes were surgically removed and defolliculated in 2 mg (522 U)/ml col- 
lagenase (Worthington Biochem. Corp., Freehold, NJ) in 82.5 mM NaCI, 
2 mM KCI, 1 mM MgCI2, 5 mM Hepes, adjusted to pH 7.5 with constant 
agitation at room temperature for 2-3 h.  After extensive washing in the 
above described buffer, stage 5 and 6 oocytes were selected. Staging of oo- 
cytes was according to Dumont (12). They were then kept in modified Barth 
solution (84 mM NaCI,  1 mM KC1, 2.4 mM NaHCO3, 0.82 mM MgSO4, 
0.33 mM Ca(NO3)2, 0.41 mM CaCI2, 7.5 mM Tris-HCl, pH 7.4,  100 U/rnl 
penicillin, 100 #g/ml streptomycin) at 18°C. Preincubation with Lovastatin 
was done at 50 #M. Lovastatin was a gift from Dr. M. Stapff (Merck, Sharp 
&  Dohme, Mtinchen, FRG).  To  make a  10  mM stock solution 90  mg 
Lovastatin was dissolved by heating to 55°C in 1.8 ml ethanol, 0.9 ml of 
a 0.6 N NaOH solution, and 18 ml H20 were added and incubated at room 
temperature for 30 min. pH was adjusted to 8.0 with HCI and the solution 
was brought to a final volume of 22.5 mi with H20.  This stock solution 
was kept at -20°C (25). In all labeling experiments 10 #1 of modified Barth 
solution per oocyte were used. For labeling with [3SS]methionine  (Amer- 
sham, Brannschweig, FRG) 10 #Ci/oocyte were added. [3H]Mevalonolac- 
tone (NEN Dupont, Wilmington, DE) in the presence of 50 #M Lovastatin 
was administered  at a concentration of  0.5 #Ci/oocyte. After the appropriate 
incubation period, nuclei were manually removed. To inhibit protein syn- 
thesis oocytes were incubated in 200 #g/ml cycloheximide (Sigma Chem. 
Co., St.  Louis, MO). 
Isolation and Manipulation of Oocyte Nuclei 
Oocyte nuclei were isolated manually from collagenase treated occytes as 
described previously (46). 
For the isolation of nuclei under mineral oil (38) oocytes were transferred 
to small plastic weight boats and the buffer was carefully drained with a 
piece of filter paper.  The  oocytes were then  covered with  mineral oil 
(M5904,  Sigma  Chem.  Co.).  Nuclei  were  manually  isolated  and  the 
enucleated oocytes were removed from the oil with forceps. Application of 
[3H]farnesylpyrophosphate (22.5  Ci/mmoi;  NEN  Dupont,  Wilmington, 
DE) was carded out with microcapillaries (Clark Electromedical Instru- 
ments, Reading, UK) with the help of a microsyringe. Droplets of less than 
10 7/1 were applicated. After the incubation nuclei were removed from the 
oil with a Gilson pipette equipped with a flattened tip. 
For high salt extraction nuclei were transferred into a microcentrifuge 
tube and 2 volumes of 2 M NaCI, 100 mM Tris-HCI, pH 7.4, were added. 
After 5 min incubation at 4°C the samples were spun in a microcentrifuge 
for 15 min. Supernatants were transferred to a new tube and respun. The 
pellets were resuspended in the same buffer and also spun once more. 
Preparation of Cytoplasmic Extract 
Oocytes were manually enucleated in 83 mM KCI, 17 mM NaCI,  10 mM 
Tris-HCl, pH 7.2. The enucleated oocytes were transferred into a microcen- 
trifuge tube, excess buffer was removed and the oocytes were homogenized 
by pipetting up and down with a yellow tip. The cytoplasmic homogenate 
was used without further fractionation. Lamin B3 was isolated with mag- 
netic immunobeads from isolated nuclei of Lovastatin-treated [35S]methio- 
nine-labeled oocytes. Labeling conditions were as described above.  Im- 
munobeads loaded with lamin B3 (equivalent to 10 nuclei) were incubated 
with cytoplasmic extract (equivalent to 10 oocytes) in the presence of 22 
pmole farnesylpyrophosphate (NEN Dupont, Wilmington, DE) for 16 h at 
18°C.  After the incubation the beads were washed and processed as de- 
scribed for immunoprecipitation experiments. 
Gel Electrophoresis and Fluorography 
Proteins were separated on 10 % polyacrylamide gels according to Laemmli 
(30). For the detection of 3H- and 35S-labeled proteins, gels were fixed in 
10%  acetic acid for 30 min,  incubated in Amplify (Amersham, Braun- 
schweig, FRG) for 20 min, dried, and exposed to x-ray film. 
Immunoprecipitation 
The lamin specific monoclonal murine antibody L6-5D5 (45), used in all 
experiments, recognizes Xenopus laevis lamins B3 and to a lesser extent 
B2  in immunoblots. In immunoprecipitations, however,  this antibody is 
specific for lamin B3,  there is no precipitation of B2 to any  significant 
degree. 
All immunoprecipitations were carried out with magnetic MP450 Dy- 
nabeads precoated with anti-mouse IgG antibodies (Dynal, Oslo, Norway). 
The beads were incubated under constant agitation with anti-lamin mono- 
clonal antibody at 4"C for 12 h. They were then washed five times in PBS 
(140 mM NaCI, 2.7 mM KC1, 8.1 mM Na2HPO4,  1.5 mM KH~PO4, pH 
7.3) and resuspended in immunoprecipitation buffer (1% Triton X-100,  1% 
deoxycholate, 0.1% SDS, 20 mM Tris-HCl, pH 7.2,  150 mM NaCI, 2 mM 
EDTA, 20 mM methionine, 0.1 mM PMSF, 0.5% Trasyiol) (Bayer, Lever- 
kusen, FRG). Nuclei and high salt pellet fractions were solubilized in 0.4% 
SDS, 0.05 M Tris-HCl, pH 7.4, 0.1 M NaCI, 2 mM EDTA and boiled for 
5 min. The solution was brought to a final concentration of 3 % Triton X-100 
and an equal volume of 2x  immunoprecipitation buffer was added. Enu- 
cleated oocytes were homogenized in 10 #1 extraction buffer/oocyte (80 mM 
glycerophosphate, 20 mM EGTA, 15 mM MgC12, 20 mM Hepes, adjusted 
to pH 7.5, 0.5 mM PMSF) and an equal volume of 2× immunoprecipitation 
buffer was added. The antigen solutions were then preincubated with Dy- 
nabeads precoated with anti-mouse IgGs for 30 min. After removal of the 
beads, anti-lamin-coated beads were added and incubated at 4°C for 12 h 
with constant rotation. The antigen loaded beads were washed five times 
with imunoprecipitation buffer and the antigen was removed from the beads 
by boiling for 5 min in SDS-gel sample buffer. 
Results 
To analyze the isoprenylation kinetics of newly synthesized 
nuclear lamins we have chosen amphibian oocytes as ex- 
perimental system. Amphibian oocytes express lamin B3 as 
their major lamin constituent (27, 46) and B3 is readily ra- 
diolabeled in vivo by either [3sS]methionine or [3H]meva- 
Ionic acid, the biosynthetic precursor of isoprene derivatives 
The Journal  of Cell Biology,  Volume 129, 1995  18 (13).  Furthermore, nuclear and  cytoplasmic fractions can 
easily be obtained by manual  enucleation of oocytes, fa- 
cilitating kinetic analysis of nuclear uptake of lamin poly- 
peptides.  For this analysis we used a monoclonal antibody 
(L6-5D5)  that  specifically  immunoprecipitates  Xenopus 
lamin B3 but not lamin B2, which has recently been shown 
to be expressed in oocytes as a minor component (32) (see 
also Materials and Methods). We have shown previously that 
immunoprecipitation  in  conjunction  with  SDS-gel  elec- 
trophoresis allows to distinguish between the unprocessed 
and the isoprenylated form of lamin B3 (13). 
Isoprenylation of  Nuclear Lamin B3 Occurs 
in the Cytoplasm before Nuclear Uptake 
To determine the time when isoprenylation of newly synthe- 
sized lamins occurs relative to nuclear uptake we carried out 
a kinetic analysis of lamin prenylation in oocytes. Oocytes 
were labeled in medium containing [35S]methionine.  After 
1 h  the medium was changed and  [35S]methionine  was re- 
placed by an excess of unlabeled methionine. Oocytes were 
manually  enucleated  at  different  times  during  the  chase 
period and lamin B3 was immunoprecipitated from both the 
cytoplasm and the nuclei, followed by SDS-PAGE analysis. 
Fig.  1 shows the results of such a pulse chase experiment. 
After the labeling period of 1 h >  90 % of the radiolabeled 
lamin B3 is still found in the cytoplasm (Fig. 1, lane 2). Both 
forms of B3,  the isoprenylated faster migrating  and,  less 
abundant, the unmodified slower migrating form of B3 are 
present in the cytoplasm (Fig.  1, lane 2). After a 5 h chase 
period, and probably before that time, the newly synthesized 
lamin B3 is completely converted to the isoprenylated form 
(Fig. 1, lanes 3 and 4). Nuclear entry of lamin B3 is slower; 
accumulation of the fully processed form within the nucleus 
is observed over the entire chase period. Quantification of 
the results by phosphoimaging revealed, that: (a) the [~ss]- 
methionine-labeled lamin B3 is  stable throughout this pe- 
riod, and that (b) B3 had accumulated about 16-fold in the 
nucleus after 24 h. The observed rate of nuclear accumula- 
tion of lamin B3 is within the broad range of other oocyte 
nuclear  proteins.  Moreover,  in  nuclei  only isoprenylated 
lamin is detected. From these results it can be concluded that 
isoprenylation of newly synthesized nuclear lamins occurs in 
the oocyte cytoplasm and precedes the uptake of these pro- 
teins into the nucleus. 
In  line  with  these  findings  is  the  observation that  iso- 
prenylated lamin B3,  radiolabeled by its isoprene moiety, 
can be immunoprecipitated from the cytoplasm of oocytes 
that  had  been  metabolically  labeled  with  [3H]mevalonlc 
acid  (Fig.  2,  lane 2).  Comparison of immunoprecipitates 
Figure 1. Lamin B3 is isoprenylated in the cytoplasm before uptake 
into  the  nucleus. Oocytes  were  biosynthetically  labeled  with 
[35S]methionine for 1 h, [35S]methionine  was then replaced by un- 
labeled methionine and nuclei were isolated immediately after the 
pulse-labeling period (1 h) and after 5, 11, and 23 h of  chase respec- 
tively. Lamin B3 was detected after immunoprecipitation and SDS- 
PAGE by fluorography for 3 d. The immunoprecipitate of 40 nuclei 
(N, lanes 1, 3, 5, 7) or 40 enucleated oocytes (C, and 2, 4, 6, 8), 
respectively, were loaded per lane.  The size of molecular mass 
markers is given in kD at left. 
Figure 2.  Analysis of lamin isoprenylation in oocyte cytoplasm 
(Lanes 1 and 2) Lamin B3, radiolabeled in its isoprene group, can 
be isolated from oocyte cytoplasm.  Oocytes were incubated in 
Lovastatin and [3H]mevalonic  acid for 48 h. Nuclei were isolated 
manually and lamin B3 was immunoprecipitated from nuclei and 
enucleated oocyte cytoplasm. B3 precipitated from 25 nuclei (lane 
1 ) and 100 oocyte cytoplasm equivalents (lane 2) was analyzed by 
SDS-PAGE followed by fluorography. (Lanes 3 and 4) In vitro 
isoprenylation of lamin B3 by incubation in extracts of enucleated 
oocytes. For preparation of the extract see Materials and Methods. 
Unmodified [35S]methionine-labeled  lamin B3,  equivalent to  10 
oocyte nuclei, was isolated from mevalonic acid starved oocytes by 
immunoprecipitation with magnetic beads. The B3 loaded beads 
were incubated with farnesylpyrophosphate for 16 h either in the 
absence (lane 3) or presence of  oocyte cytoplasmic extract, equiva- 
lent to 10 oocytes, (lane 4). They were then washed and processed 
for immunoprecipitation as described. Proteins were analyzed by 
SDS-PAGE and visualized by fluorography. Exposure to x-ray film 
was for 14 d 0anes I and 2) and 16 h (lanes 3 and 4) respectively. 
Note that recovery from samples incubated with cytoplasm (lane 
4) was always  lower than from controls (lane 3). The size of  molec- 
ular mass markers is given in kD at left. 
Firmbach-Kraft  and Stick lsoprenylation of Lamin B3  19 from nuclei (lane 1 ) and cytoplasm (lane 2) shows that only 
a small fraction of fully processed lamin B3 can be detected 
in the cytoplasm (for gel loading amounts see legend to 
Fig. 2). Moreover, we tested crude cytoplasmic extracts of 
enucleated oocytes for  their  ability to  prenylate  nuclear 
lamin  B3  in  vitro.  Unmodified,  [~sS]methionine-labeled 
lamin B3 was isolated from nuclei of mevalonic acid starved 
oocytes by immunoprecipitation with magnetic beads (for 
details see Materials and Methods). These lamin B3-1oaded 
beads were incubated in cytoplasmic extracts in the presence 
of farnesylpyrophosphate, the direct precursor of the far- 
nesyl moiety. Although incubation with cytoplasmic extract 
reproducibly lowered the recovery of lamin B3, it resulted in 
the appearance of a  faster migrating band in SDS-PAGE, 
which corresponds to the isoprenylated form of B3 (Fig. 2, 
lane 4), as compared to an untreated control sample (Fig. 
2, lane 3). This experiment shows that nuclear lamins can 
be isoprenylated in vitro by cytoplasmic protein farnesyl- 
transferases of Xenopus oocytes. 
Evidence for a Nuclear Protein 
lsoprenyltransferase  Activity 
The analysis of the processing pathway of prelamin A in so- 
matic cells has been interpreted in favor of the view that 
prelamin A undergoes its posttranslational modifications in 
the nucleus rather than in the cytosol (33).  Consistent with 
this view both subunits of protein farnesyltransferase have 
been  detected in nuclei of CHO cells by  indirect immu- 
nofluorescence techniques (44).  We had previously shown 
that treatment of  oocytes with Lovastatin results, like in other 
cells, in the accumulation of non-isoprenylated lamin poly- 
peptides  in  the  nucleoplasm  (13). We  therefore  asked 
whether these lamin polypeptides can be processed upon 
replenishing the isoprenoid pools by exogenous administra- 
tion of mevalonic acid. To follow the fate of lamin B3 in this 
experiment  oocytes  were  first  preincubated  for  12 h  in 
I.~vastatin to exhaust the endogenous isoprenoid pool. Pro- 
teins were then radiolabeled with [35S]methionine for 12 h. 
The medium was changed and [35S]methionine was chased 
out by incubation with an excess of unlabeled methionine. 
Mevalonic acid was added to the medium and incubation was 
continued for another 12 h (Fig. 3, lane 2). To one part of 
the oocytes cycloheximide was added to inhibit de novo pro- 
tein synthesis (Fig.  3,  lane 3).  Control oocytes were  in- 
cubated in the absence of mevalonic acid and cycloheximide 
(Fig. 3, lane 1 ). At the end of  the incubation time nuclei were 
manually isolated and lamin B3 was processed by immuno- 
precipitation and SDS-PAGE as described above. As can be 
seen in Fig. 3 replenishing of isoprenoid pools leads to con- 
version of the unprocessed form of B3, that had been accu- 
mulated in the nucleoplasm, to the faster migrating, iso- 
prenylated form  (compare  Fig.  3,  lanes  2  and  1).  This 
conversion also occurs when protein synthesis is blocked by 
cycloheximide (Fig. 3, lane 3). The simplest explanation of 
these results would be, that under these experimental condi- 
tions lamin isoprenylation takes place within the nucleus. 
The unmodified lamin B3 in the nucleoplasm is, however, 
soluble (see below) and it can therefore not be ruled out that 
it shuttles back into the cytosol. After addition of mevalonic 
acid it might be isoprenylated in the cytoplasm before reen- 
tering the nucleus. 
Figure  3.  Isoprenylation of 
lamin B3 in oocyte nuclei in 
vivo. Oocytes were incubated 
in Lovastatin  for 12 h, proteins 
were then radiolabeled with 
[3~S]methionine in  the  pres- 
ence of Lovastatin for 12 h. 
The oocytes were transferred 
into fresh medium containing 
an excess of unlabeled methi- 
onine and were incubated for 
another 12 h. Mevalonic acid 
(M  +)  was then added and 
oocytes  were incubated for 
another  12  h  either  in  the 
absence  (C  -)  (lane  2)  or 
presence (C +) of cyclohexi- 
mide  (lane 3),  or  oocytes 
were processed directly, omit- 
ting the incubation  with meva- 
Ionic acid  (M  -)  (lane 1). 
Nuclei were isolated  manually 
and lamin B3 was detected af- 
ter  immunoprecipitation and 
SDS-PAGE by  fluorography. 
Exposure to x-ray film was for 5 h. The size of molecular mass 
markers is given in kD at left. 
Lamins Can Be lsoprenylated  in Isolated Nuclei 
To further investigate the possibility of shuttling of unmod- 
ified lamin B3, we carried out an in vitro farnesylation ex- 
periment with isolated nuclei. The outline of this experiment 
is explained in Fig. 4. Depletion of endogenous isoprenoids 
and labeling of proteins was carried out as in the previous 
experiment, oocytes were then transferred into mineral oil 
and nuclei were manually isolated free of  cytoplasm and kept 
under oil. Nuclei isolated in this manner remain metaboli- 
caUy active for prolonged periods of time. They faithfully 
carry out protein im- and export and are active in RNA syn- 
thesis (38).  To test the ability of the nuclei to process lamin 
B3,  microdroplets containing farnesylpyrophosphate were 
added to individual nuclei. After incubation for 16 h lamin 
B3  was  isolated by immunoprecipitation and analyzed by 
SDS-PAGE as described above. The results of two indepen- 
dent experiments are shown in Fig. 5  (lanes 1-3 and 4-6, 
respectively). It is evident from the gel electrophoretic com- 
parison of lamin B3 isolated from untreated oocyte nuclei 
(Fig. 5, lane 1 ) to B3 isolated from oocyte nuclei incubated 
with farnesylpyrophosphate, that B3 can be processed to the 
mature form in isolated nuclei (Fig. 5, lanes 3 and 4). This 
processing is dependent on the addition of farnesylpyrophos- 
phate 0~ig. 5, lanes 3  and 4)  since without any additions 
(lane 2) or addition of buffer alone (lane 5) B3 remains un- 
processed. Incorporation of the farnesyl moiety can be dem- 
onstrated directly by incubation of nuclei, isolated from un- 
labeled  oocytes,  with  [3H]farnesylpyrophosphate (Fig.  5, 
lane 6). 
Isoprenylation is a prerequisite for the incorporation of 
lamin polypeptides into the nuclear lamina structure. Lam- 
ins form intermediate type filaments that are resistant to ex- 
traction with buffers containing high salt concentrations (1, 
16, 46).  To see whether this process can occur in isolated 
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Figure  4.  Isoprenylation of lamin B3  in isolated  oocyte nuclei. 
Scheme of the experimental  design.  Oocytes were preincubated  in 
Lovastatin  for 16 h and proteins were radiolabeled  with  [35S]me- 
thionine  in the presence of Lovastatin  for 16 h. The oocytes were 
then transferred  into mineral oil and nuclei  (GV) were manually 
isolated.  After addition  of microdroplets of farnesylpyrophosphate 
(farnesyl-PP) to the nuclei, incubation was continued for 16 h fol- 
lowed  by immunoprecipitation of lamin  B3,  gel  electrophoretic 
analysis  and detection by fluorography. 
nuclei we transferred nuclei that had been incubated with far- 
nesylpyrophosphate as described above into high salt buffer 
and  fractionated  them  by  centrifugation  into  a  high  salt- 
resistant pellet and a supernatant  fraction. While in the ab- 
sence of farnesylpyrophosphate  only a minute amount of B3 
is found in the pellet fraction (compare Fig. 6, lanes 2  and 
3),  a  significant amount of B3  becomes high salt resistant 
after in vitro farnesylation  (Fig. 6, lanes 5 and 6). This indi- 
cates  that  the  farnsylated  lamin polypeptides  are incorpo- 
rated  into the  existing  lamin  filaments  in  isolated  nuclei. 
While in vitro farnesylation  of lamin B3 is carried out with 
high efficiency (see Fig. 5) the conversion of B3 into a high 
salt-resistant  fraction  is  not  complete.  This  might be  ex- 
plained by the  fact,  that  in contrast to the enzymatic  iso- 
prenylation  reaction,  incorporation  of B3  into the  lamina 
structure is a relatively slow process and not all nuclei might 
be fully functional over the long in vitro incubation period. 
Figure 5. Detection of lamin B3 isoprenylated  in isolated  nuclei as 
outlined  in Fig. 4. (Lane 1 ) Isoprenylated lamin B3 from control 
oocytes; (lane 2) unprocessed B3 from isolated nuclei of Lovastatin 
treated  oocytes with no additions  (-).  (Lanes 3 and 4) Lamin B3 
immunoprecipitated  from isolated nuclei of Lovastatin treated oo- 
cytes after addition of farnesylpyrophosphate  (+FPP); (lane 5) B3 
from isolated  nuclei of Lovastatin treated oocytes after addition of 
buffer alone (+ buffer). Results of  two independent experiments  are 
shown in lanes 1-3 and 4-5, respectively. For the experiment  shown 
in lanes 1-3 five nuclei were processed per lane, for the experiments 
shown in lanes  4-5 10 nuclei  were processed per lane.  The same 
type of  experiment was carried out with unlabeled nuclei. Isopreny- 
lation of lamin B3 was directly demonstrated by adding microdrop- 
lets of [3H]farnesylpyrophosphate  to the nuclei (lane 6). 30 nuclei 
were processed for this experiment.  Exposure times were 2 d for 
lanes  1 to 3,  1 d for lanes  4 and 5, and  17 d for lane 6.  The size 
of molecular mass markers is given in kD at left. 
Discussion 
In this study we report on the isoprenylation of  nuclear lamin 
B3 in Xenopus  oocytes. We have used in vivo kinetic analysis 
to  determine  when  after de  novo  synthesis lamin  B3  is 
isoprenylated relative to its uptake into the nucleus. We fur- 
ther analyzed the  capacity  of isolated  nuclei  to carry out 
isoprenylation  of B3  and  its  integration  into  the  lamina 
structure. 
Kinetic Analysis of  Lamin B3 Isoprenylation 
Two topogenic sequences are responsible for targeting  nu- 
clear lamins to the inner nuclear membrane, the nuclear lo- 
calization signal and the COOH-terminal CXXX motif that 
is the major determinant of a series of posttranslational  mod- 
ifications including  isoprenylation,  proteolytic processing, 
and carboxyl methylation (21,  26, 28, 31, 44, 47).  While it 
is clear that both signals are necessary for correct targeting 
of lamins (21) it is not known bow the action of the two sig- 
nals is concerted, i.e., whether isoprenylation occurs in the 
cytoplasm prior to nuclear uptake,  or whether lamins are 
first transported  into the nucleoplasm where they are then 
Firmbach-Kraft and Stick Isoprenylation of Lamin B3  21 Figure 6. Lamin B3, isoprenylated in isolated nuclei, is incorpo- 
rated  in the lamina structure.  Oocytes and isolated nuclei were 
processed as outlined in Fig. 4. After the incubation of the isolated 
nuclei in the presence (+) (lanes 4-6) or absence (-) (lanes 1-3) 
of farnesylpyrophosphate, nuclei were either processed directly for 
immunoprecipitation with the lamin-specific monoclonal antibody 
L6-5D5 (lanes 1 and 4) (T) or transferred into a buffer containing 
high salt and fractionated by centrifugation into a high salt resistant 
pellet fraction (P) (lanes 2 and 5) and a supernatant fraction (S) 
(lanes 3 and 6) before immunoprecipitation. The following num- 
bers of nuclei were processed in each lane: lanes I and 4, 5 nuclei; 
lanes 2 and 3, 15 nuclei; lanes 5 and 6, 25 nuclei. Lamin B3 was 
detected after immunoprecipitation and SDS-PAGE by fluorogra- 
phy. Exposure to x-ray film was for 1 d. The size of  molecular mass 
markers is given in kD at left. 
modified by a nuclear protein farnesyltransferase. The latter 
pathway would prevent the potential misrouting of nuclear 
lamins to cytoplasmic membranes due to the addition to the 
lipophilic modifications before nuclear entry. In fact, mutant 
lamins that lack a  nuclear localization signal show a  non- 
homogeneous  cytoplasmic  distribution  after  transfection 
into cultured cells, suggesting that they might be associated 
with  cytoplasmic  endomembranes  (20,  21).  Experiments 
that could discriminate between the two possibilities have so 
far been inconclusive. While interpretation of kinetic data 
favor the view that lamin  isoprenylation is  a  cytoplasmic 
event (26), studies involving inhibitors of isoprenoid synthe- 
sis have been taken as evidence that lamins undergo post- 
translational  processing in  the  nucleus rather than in  the 
cytosol (33, 44). The kinetic analysis presented here clearly 
shows that isoprenylation of lamin B3 is a much faster event 
than nuclear uptake and that non-isoprenylated B3 does not 
enter the nucleus to a significant extent (Fig.  1). The most 
straightforward interpretation of these results is, that, under 
normal conditions, isoprenylation of lamin B3 occurs in the 
cytoplasm and that nuclear uptake is dominant over associa- 
tion of isoprenylated B3 with cytoplasmic membranes. This 
raises the question whether newly synthesized lamins are 
freely soluble in the cytosol or whether they become tran- 
siently associated with cytoplasmic membranes on their way 
to the nuclear pore complexes. Membrane association might 
influence the kinetics of nuclear uptake. The observed rate 
of nuclear accumulation of lamin B3  is  within the broad 
range of rates of other, non-prenylated, oocyte nuclear pro- 
teins and therefore does not give a clue toward one or the 
other possibility. A direct comparison of the nuclear uptake 
kinetics  of  isoprenylated  and  mutant  non-isoprenylated 
lamin might give hints whether transient membrane binding 
is involved in nuclear migration of CXXX-modified lamins. 
It has  been shown in  several experimental systems that 
protein isoprenylation is not sufficient to confer membrane 
attachment (7, 13, 17) and that other factors must be involved 
in a tight membrane binding of isoprenylated proteins (18). 
Several  integral  membrane  proteins  of the  inner  nuclear 
membrane have been characterized that interact with lamins 
(2,  14,  34,  37,  42, 43,  49).  One of these contains several 
membrane spanning domains of unknown function (48). It 
has been speculated that these hydrophobic domains might 
interact with  the  farnesyl groups  of lamins.  This protein 
might act as a lamin farnesyl receptor (20, 35) and might de- 
termine the specific association of lamins with the inner nu- 
clear membrane. 
In vitro studies with synthetic peptides have shown that the 
substrate requirements of purified protein farnesyltrasferase 
are confined to the CXXX tetrapeptide (39). It is therefore 
likely  that  the  same  cytosolic  enzyme  carries  out  the 
isoprenylation of  cytoplasmic proteins like Ras, cGMP phos- 
phodiesterase ct and nuclear lamins.  Our observation that 
immunopurified lamin B3 can be isoprenylated by crude cy- 
toplasmic extracts of enucleated oocytes is in line with this 
assumption. 
Isoprenylation of  Lamins in Nuclei 
Our finding that lamins are isoprenylated in the cytoplasm 
before  entry  into  the  nucleus  contradicts  the  conclusion 
drawn from the analysis of the processing pathway of lamin 
A in cell culture cells (33). In these experiments the cellular 
isoprene pools were depleted by treatment of the cells with 
Lovastatin  to  facilitate the  analysis  of isoprenylation.  In 
isoprene depleted cells lamins  accumulate  in  the  nucleo- 
plasm. Upon replenishment of isoprene pools by administra- 
tion of mevalonic acid, lamins are rapidly isoprenylated and 
incorporated into  the  nuclear  lamina  structure.  This  has 
been taken as evidence for a  nuclear localization of lamin 
processing (33,  44).  We report identical results in experi- 
ments  with  Lovastatin-treated oocytes (Fig.  3)  ruling  out 
differences  in  the  experimental  systems.  Nucleoplasmic 
lamin B3 is isoprenylated and incorporated into the lamina 
after addition of mevalonic acid to isoprene starved oocytes 
(Fig. 3;  13).  The isoprenylation is also observed when pro- 
tein synthesis is blocked by cycloheximide (Fig.  3).  How- 
ever, nuclear accumulation of non-prenylated lamins does 
not occur to a  significant extend under normal conditions 
(Fig.  1),  it rather represents a default pathway in isoprene 
starved cells. Moreover, although the above mentioned ob- 
servations suggest that isoprenylation can take place in the 
nucleus they cannot be taken as a firm proof. It might be pos- 
sible that shuttling of non-isoprenylated lamins occurs be- 
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been shown for nuclear proteins that do not tightly bind to 
an intranuclear component (5, 41). However, the in vitro ex- 
periments  with  isolated oocyte nuclei,  described  in  this 
study, suggest that isoprenylation might indeed take place in 
the nucleus. This interpretation is supported by the demon- 
stration of both subunits of protein farnesyltransferase in the 
nucleus of mammalian cell culture cells by immunofluores- 
cence methods (44).  However,  both methods of detection, 
i.e., monitoring the enzymatic activity in isolated nuclei de- 
scribed here, and the localization by immunofluorescence  mi- 
croscopy (44) are indirect. A firm proof of the presence of 
a protein farnesyltransferase in the cell nucleus has to await 
the  isolation and biochemical characterization of the en- 
zyme(s). 
Whether cytosolic and nuclear protein farnesyltransfer- 
ases  will represent distinct proteins remains to be deter- 
mined. Sequences for the o~ and/~ subunits of these enzymes 
have been determined for several species (for review see 
references 6, 9, 40). There is no obvious nuclear localization 
signal of the polybasic SV-40 T antigen (24) or the bipartite 
nucleoplasmin type (11) in either of these sequences, posing 
the question of the mechanism of nuclear localization of 
these polypeptides. 
The  existence  of a  nuclear  protein  farnesyltransferase 
could explain the different sensitivity of nuclear lamins ver- 
sus other (cytoplasmic) proteins to a specific class of protein 
farnesyltransferase inhibitors, the benzodiazapine peptido- 
mimetics. It has been found that isoprenylation of the Triton 
X-100-insoluble lamins is much less impaired by benzodia- 
zapine peptidomimetics than the  isoprenylation of Triton 
soluble proteins  like Ras and other cytoplasmic proteins 
(23). In light of our findings this could be explained if newly 
synthesized lamins, that are normally isoprenylated in the 
cytoplasm, enter the nucleus unmodified, similarly as  in 
isoprene starved cells. They might then be isoprenylated in 
the nucleoplasm either due to a different accessibility of the 
peptidomimetics to the nuclear compartment or due to a 
different sensitivity of  the nuclear protein farnesyltransferase 
to the inhibitors. Since these substances have been shown to 
be potent inhibitors of oncogenic Ras in animal cells, it will 
be worth learning more about their specific action. Due to 
the ease with which amphibian oocytes can be isolated and 
manipulated, Xenopus oocytes might be a suitable biological 
system to undertake a more detailed biochemical character- 
ization of nuclear protein farnesyltransferases as well as to 
study the accessibility of peptidomimetic protein farnesyl- 
transferase inhibitors to nuclei. 
Since our studies have shown that nuclear isoprenylation 
of lamins is a default pathway rather than a reflection of the 
normal in vivo situation, the question of the in vivo function 
of nuclear protein farnesyltransferase(s) is raised. The Xeno- 
pus oocyte nucleus contains several other polypeptides in ad- 
dition to lamin B3 that are radiolabeled upon incubation of 
oocytes with [3H]mevalonic acid (our unpublished observa- 
tion). A nuclear enzyme might therefore act on other nuclear 
CXXX  motif proteins.  Alternatively, as  shown for other 
modifications,  protein  function  might  be  modulated  by 
deisoprenylation and reisoprenylation. So far, however,  no 
loss of isoprenyl groups has been observed in mammalian 
Ras proteins (19) and B-type nuclear lamins (13). If an un- 
modified COOH-terminal cysteine residue would be regen- 
erated by deisoprenylation of  a mature isoprenylated protein, 
its  reisoprenylation would depend on an  enzyme with  a 
different substrate requirement than the CXXX-dependent 
protein farnesyltransferase (for discussion see reference 9). 
Such enzymes might be expected to have different sensitivity 
to peptidomimetics that were designed to inhibit CXXX- 
dependent protein farnesyltransferases. 
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